Offer - Urjas Oil for just ₹ 1 X
Tacroderm 0.1 Ointment is a commercial drug that is prescribed in the form of Ointment. It is typically used for the treatment of Liver transplant, Kidney transplant, Heart Transplant. Secondary and off-label uses of Tacroderm 0.1 Ointment have also been mentioned below.
The optimal dosage of Tacroderm 0.1 Ointment is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Tacroderm 0.1 Ointment side effects, there are can be others also. These have been listed below. Usually, these side effects of Tacroderm 0.1 Ointment go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Tacroderm 0.1 Ointment is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Tacroderm 0.1 Ointment's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Infections, Diabetes Type 2 must refrain from the use of Tacroderm 0.1 Ointment since this can cause severe adverse effects. Other contraindications of Tacroderm 0.1 Ointment have been discussed in the sections ahead.
Drug interactions for Tacroderm 0.1 Ointment have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Tacroderm 0.1 Ointment, it is important to know that it is safe while driving, and is habit-forming.
Tacroderm 0.1 Ointment is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Tacroderm 0.1 Ointment safe for pregnant women?
Tacroderm can have harmful effects in pregnant women. If you experience any discomfort after using Tacroderm, then discontinue the use and take your doctor's advice.
Is the use of Tacroderm 0.1 Ointment safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Tacroderm. Immediately discontinue Tacroderm if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Tacroderm 0.1 Ointment on the Kidneys?
Tacroderm can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Tacroderm 0.1 Ointment on the Liver?
There may be an adverse effect on the liver after taking Tacroderm. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Tacroderm 0.1 Ointment on the Heart?
There may be severe side effects of Tacroderm on your heart. Do not take it unless a doctor says so.
If you are suffering from any of the following diseases, you should not take Tacroderm 0.1 Ointment unless your doctor advises you to do so -
Is this Tacroderm 0.1 Ointment habit forming or addictive?
Forming a habit of Tacroderm 0.1 Ointment has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Tacroderm 0.1 Ointment will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Tacroderm 0.1 Ointment should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Tacroderm 0.1 Ointment in mental disorders is not effective.
Interaction between Food and Tacroderm 0.1 Ointment
Due to a lack of research, nothing can be said about the consequences of taking Tacroderm 0.1 Ointment together with food.
Interaction between Alcohol and Tacroderm 0.1 Ointment
Consuming Tacroderm 0.1 Ointment with alcohol can have many serious effects on your body.
No, Tacroderm is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take for this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before using this medication by himself or herself.
Yes, Tacroderm may cause hair loss. The patients who are taking this drug are at risk of alopecia (hair loss). If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor immediately.
Tacroderm work by reducing the activity of the immune system so it cannot attack the transplanted organ. Hence in this way, it prevents the rejection of organ transplants.
No, you cannot take the Tacroderm with clarithromycin, as it may change the effect of the Tacroderm and cause some serious side effects, always consult your doctor before taking this drug combination.
Tacroderm is a brand name of tacrolimus and it is available in the form of a capsule, granules for oral suspension, an extended-release tablet, injectables, and ointment. It belongs to the class of drugs known as immunosuppressants. Tacroderm is a prescription drug that is used to prevent the rejection of organ transplants (liver and kidney). The topical form of Tacroderm is used to treat eczema.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167